MMRF Meetings at ASH
? Thursday, December 10, 2026
? 10:00 AM – 6:30 PM CT
? Courtyard New Orleans Warehouse Arts District
Join the Multiple Myeloma Research Foundation in New Orleans for a full day of clinical and scientific collaboration alongside the American Society of Hematology (ASH) Annual Meeting. Bringing together Multiple Myeloma Research Consortium (MMRC) site leaders, clinical investigators, translational researchers, and biopharma partners, these meetings will advance ongoing MMRF-led research and shape the future of multiple myeloma treatment.
The day will include the annual Multiple Myeloma Project Manager (MMPM) Meeting, the MMRF Immunity Workshop, the Clinical Research Committee Investigator Meeting, and an evening reception. See individual meeting descriptions below.
Meeting Overviews
MMRC Multiple Myeloma Project Manager (MMPM) Meeting
10:00 AM – 12:00 PM
The 2026 annual MMPM meeting will be a hybrid gathering of key MMRC site leaders, led by Katie Wozniak, SVP Clinical Research and Regulatory Affairs, and Mercedes Martillo, Associate Director, Clinical Operations at the MMRF. Topics will include clinical operations, regulatory updates and discussion around MMRC Horizon One: RRMM and Horizon Two: HR NDMM trials, as well as the TRU-001 study. In addition, open discussion and Q&A regarding MMRC site experience and clinical operational considerations will be covered. Finally, MMRC leadership will share a preview of 2027 research initiatives and associated MMRC site goals.
MMRF Immunity Workshop
1:00 PM – 3:00 PM
MMRF hosts academic (both clinical and translational research) and biopharma partners to discuss ongoing MMRF-led research in immunology-related topics and future directions of our combined research efforts. The themes for this year’s roundtable discussion include insights from immune microenvironment from the MMRF Immune Atlas Network and data-driven hypothesis development needed for our continued understanding of disease progression and treatments. This private MMRF event will include short presentations to initiate discussions and brainstorming sessions on the most recent insights from immune analyses and how these studies inform clinical studies and drive future collaborations.
MMRC Clinical Research Committee (CRC) Investigator Meeting
3:00 PM – 5:00 PM
MMRF Chief Medical Officer Hearn Jay Cho, Chief Scientific Officer George Mulligan, and SVP Clinical Research and Regulatory Affairs Katie Wozniak will present an overview of 2026 MMRC performance and current clinical research studies, including Horizon One: RRMM, Horizon Two: HR NDMM, and the Translational Research Umbrella (TRU) study initiatives. Details around the 2027 MMRC site governance model, strategic plans, and research initiatives will also be shared. Open dialogue and expert input regarding proposed concepts are encouraged.
MMRF Reception
5:15 PM – 6:30 PM
Join MMRF leadership, MMRC investigators, and partners for an evening reception to close the day.